The market for IBAT inhibitors is projected to experience significant growth in the near future, fueled by the rising incidence of genetic disorders, a...
WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, today announced its top-line revenue forecast for its specialty care pipeline, projecting nearly $1 billion in revenue in its launch year and a cumulative 5-year estimate of between $18 billion and $22 billion. This forecast reflects the company’s unique, faster, and cost-efficient drug development model which has the potential to serve as a blueprint to ensure sustainable medical innovation for years to come.
The global microgrid market is witnessing rapid growth, primarily driven by the rising demand for energy resilience and reliability, especially in the face of grid...
The global microgrid market is witnessing rapid growth, primarily driven by the rising demand for energy resilience and reliability, especially in the face of grid...
The smart cities market is anticipated to expand at a rapid pace due to rapid urbanization and escalating population.
WESTFORD, Mass., Aug. 11, 2025 /PRNewswire/...
The activated carbon market is anticipated to expand at a rapid pace due to rising global demand for clean water, and effective wastewater treatment.
WESTFORD,...
The activated carbon market is anticipated to expand at a rapid pace due to rising global demand for clean water, and effective wastewater treatment.
WESTFORD,...
WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders.
The flexible packaging market is anticipated to expand at a rapid pace owing to surging consumption of packaged foods and beverages coupled with advancements...
"With rising fire safety standards and the growing use of electric vehicles, demand for flame retardant chemicals is expanding across industries such as construction,...
WARREN, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an update on institutional ownership of the Company’s outstanding common stock, as reported by institutional investment managers on Form 13F filed with the Securities and Exchange Commission (SEC).